| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.59B | -1.0% |
| Gross Profit | $1.71B | +4.0% |
| R&D Expense | $271.0M | -5.9% |
| SG&A Expense | $674.0M | -0.1% |
| Operating Income | $498.0M | +132.0% |
| Interest Expense | $284.0M | -20.2% |
| Pre-tax Income | $180.0M | +109.3% |
| Income Tax | -$10.0M | +88.5% |
| Net Income | $190.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $420.0M | -17.2% |
| Accounts Receivable | $615.0M | +2.0% |
| Inventory | $893.0M | -9.9% |
| Current Assets | $2.47B | -8.2% |
| Total Assets | $8.59B | -5.8% |
| Current Liabilities | $775.0M | -8.6% |
| Long-term Debt | $4.49B | -4.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $528.0M | +65.5% |
| Capital Expenditures | $118.0M | +35.6% |
| Investing Cash Flow | -$117.0M | -39.3% |
| Financing Cash Flow | -$549.0M | -112.0% |
| Free Cash Flow | $410.0M | +76.7% |
| +110.3% |
| EPS (Basic) | $2.82 | +110.2% |
| EPS (Diluted) | $2.81 | +110.2% |
| Total Liabilities |
| $6.27B |
| -5.7% |
| Stockholders' Equity | $2.32B | -6.1% |